世界の臨床試験イメージング市場2021-2028:サービス別(プロジェクト・データ管理、システム・技術サポートサービス)、用途別、最終用途別、地域別

◆英語タイトル:Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Service (Project and Data Management, System and Technology Support Services), By Application, By End Use, By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MC077
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年1月15日
◆ページ数:111
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の臨床試験イメージング市場規模が2028年までに14憶ドルに達すると予測しています。2021年から2028年までに年平均6.1%成長する見通しです。本調査レポートでは、臨床試験イメージングの世界市場について調査・分析し、調査範囲、調査手法、目的、エグゼクティブサマリー、市場定義、産業動向、競争状況、サービス別(設計・コンサルティング、読み取り・分析、操作イメージング、システム・技術サポート、プロジェクト・データ管理)分析、用途別(非アルコール性脂肪性肝炎(NASH)、慢性腎臓病(CKD)、糖尿病、心血管疾患、その他)分析、最終用途別(バイオテクノロジー・製薬会社、医療機器メーカー、学術・政府研究所、委託研究機関(CRO)、その他)分析、地域別分析、企業情報などを掲載しています。
・調査範囲
・調査手法
・目的
・エグゼクティブサマリー
・市場定義
・産業動向
・競争状況
・臨床試験イメージングの世界市場規模:サービス別(設計・コンサルティング、読み取り・分析、操作イメージング、システム・技術サポート、プロジェクト・データ管理)
・臨床試験イメージングの世界市場規模:用途別(非アルコール性脂肪性肝炎(NASH)、慢性腎臓病(CKD)、糖尿病、心血管疾患、その他)
・臨床試験イメージングの世界市場規模:最終用途別(バイオテクノロジー・製薬会社、医療機器メーカー、学術・政府研究所、委託研究機関(CRO)、その他)
・臨床試験イメージングの世界市場規模:地域別
・企業情報
【レポートの概要】

Clinical Trial Imaging Market Growth & Trends

The global clinical trial imaging market size is expected to reach USD 1.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.1% from 2021 to 2028. The increasing R&D spending to develop new drugs and therapies to treat chronic diseases is propelling the market growth.

Clinical trial imaging makes use of imaging technology in clinical trials for seeing the interior parts of the body. The images obtained from clinical trial imaging are used to examine drug activity. Clinical trial imaging provides rapid, detail, and precise screening. The use of clinical trial imaging has rapidly increased in all phases of the clinical trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities, such as EMA and FDA, to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuroimaging. Imaging biomarkers are effective in radiological reads. This provides a radiological reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility.

Clinical Trial Imaging Market Report Highlights

• Based on service, project and data management services held the largest share in 2020 due to the growing requirement of data management and workflow for clinical trial imaging

• Operational imaging services held a significant share in 2020. They include imaging modalities such as MRI, CT scan, X-ray, ultrasound, OCT, PET, and SPECT. CT scan modality is gaining popularity due to its non-invasive nature and its ability to provide detailed information about the disease for enhanced treatment

• The others application segment held the largest share in 2020. This segment includes oncology, neurology, and musculoskeletal. Market players such as ICON, Bioclinica, Navitas Life Sciences, and Paraxel International are developing their clinical trial imaging services for these applications

• By end-use, CROs held the largest share in 2020 due to increasing investments in the field of research and development and snowballing outsourcing activities by the pharmaceutical and biotechnology companies to cut down the cost and time and patent expiration

• North America dominated the market in 2020 due to the increasing geriatric population, rising chronic diseases, and growing demand for treatment options

【レポートの目次】

Table of Contents

Chapter 1 Report Scope
1.1 Segment Market Scope
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
Chapter 2 Methodology
2.1 Research Methodology
2.1.1 Information Procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Region Wise Market: Base Estimates
2.4.2 Global Market: CAGR Calculation
2.5 Region-based Segment Share Calculation
2.6 Model Details
2.6.1 Commodity Flow Analysis (Model 1)
2.6.2 Volume Price Analysis (Model 2)
2.7 List of Secondary Sources
2.8 List of Primary Sources
2.9 List of Abbreviations
Chapter 3 Objectives
3.1 Objective – 1:
3.2 Objective – 2:
3.3 Objective – 3:
3.4 Objective – 4:
Chapter 4 Executive Summary
Chapter 5 Market Definition
Chapter 6 Industry Outlook
6.1 Market Segmentation
6.2 Business Segment Trends
6.2.1 Product Business Analysis
6.2.2 Regional Business Analysis
6.3 Market Variable Analysis
6.3.1 Market Driver Analysis
6.3.1.1 Growing number of pharmaceutical and biotechnology companies
6.3.1.2 Growing Number of Contract Research Organizations
6.3.1.3 Increasing Research and Development investments
6.3.2 Market Restraint Analysis
6.3.2.1 High cost of machinery and its installation
6.4 Business Environment Analysis tools
6.4.1 SWOT Analysis, By PEST
6.4.2 Porter’s Five Forces Analysis
6.4.3 Industry Analysis – Ansoff Matrix
Chapter 7 Competitive & Vendor Landscape
7.1 Participant Categorization
7.1.1 Innovators
7.2 Strategy Mapping
7.2.1 Acquisition:
7.2.2 Collaboration:
7.2.3 New Product Launch:
7.2.4 Expansion:
7.2.5 Partnerships:
Chapter 8 Segment Analysis
8.1 Clinical Trial Imaging Market: Service Movement Analysis
8.2 Clinical Trial Design and Consultation Services
8.2.1 Clinical Trial Design and Consultation Services Market, 2016 – 2028 (USD Million)
8.3 Reading and Analytical Services
8.3.1 Reading and Analytical Services Market, 2016 – 2028 (USD Million)
8.4 Operational Imaging Services
8.4.1 Operational Imaging Services Market, 2016 – 2028 (USD Million)
8.4.2 Computed Tomography (CT) Scan
8.4.2.1 Computed Tomography Scan Market, 2016 – 2028 (USD Million)
8.4.3 Magnetic Resonance Imaging (MRI)
8.4.3.1 Magnetic Resonance Imaging (MRI) Market, 2016 – 2028 (USD Million)
8.4.4 X-ray
8.4.4.1 X-ray Market, 2016 – 2028 (USD Million)
8.4.5 Ultrasound
8.4.5.1 Ultrasound Market, 2016 – 2028 (USD Million)
8.4.6 Optical Coherence Tomography (OCT)
8.4.6.1 Optical Coherence Tomography (OCT) Market, 2016 – 2028 (USD Million)
8.4.7 Others
8.4.7.1 Others Market, 2016 – 2028 (USD Million)
8.5 System and Technology Support Service
8.5.1 System and Technology Support Services Market, 2016 – 2028 (USD Million)
8.6 Project and Data Management Services
8.6.1 Project and Data Management Services Market, 2016 – 2028 (USD Million)
Chapter 9 Application Outlook
9.1 Clinical Trial Imaging Market: Application Movement Analysis
9.2 Nonalcoholic Steatohepatitis (NASH)
9.2.1 Nonalcoholic Steatohepatitis Market, 2016 – 2028 (USD Million)
9.3 Chronic Kidney Disease (CKD)
9.3.1 CKD Market, 2016 – 2028 (USD Million)
9.4 Diabetes
9.4.1 Diabetes Market, 2016 – 2028 (USD Million)
9.5 Cardiovascular Diseases
9.5.1 Cardiovascular Diseases Market, 2016 – 2028 (USD Million)
9.6 Others
9.6.1 Others Market, 2016 – 2028 (USD Million)
Chapter 10 End-use Outlook
10.1 Clinical Trial Imaging Market: End-use Movement Analysis
10.2 Biotechnology and Pharmaceutical Companies
10.2.1 Biotechnology and Pharmaceutical Companies Market, 2016 – 2028 (USD Million)
10.3 Medical Devices Manufacturers
10.3.1 Medical Devices Manufacturers Market, 2016 – 2028 (USD Million)
10.4 Academic and Government Research Institutes
10.4.1 Academic and Government Research Institutes Market, 2016 – 2028 (USD Million)
10.5 Contract Research Organizations (CROs)
10.5.1 Contract Research Organization (CROs) Market, 2016 – 2028 (USD Million)
10.6 Others
10.6.1 Others Market, 2016 – 2028 (USD Million)
Chapter 11 Regional Outlook
11.1 Clinical Trial Imaging Market: Regional Movement Analysis
11.2 North America
11.2.1 North America Clinical Trial Imaging Market, 2016 – 2028 (USD Million)
11.2.2 U.S.
11.2.2.1 U.S. clinical trial imaging market, 2016 – 2028 (USD Million)
11.2.3 Canada
11.2.3.1 Canada clinical trial imaging market, 2016 – 2028 (USD Million)
11.3 Europe
11.3.1 Europe Clinical Trial Imaging Market, 2016 – 2028 (USD Million)
11.3.2 U.K.
11.3.2.1 U.K. clinical trial imaging market, 2016 – 2028 (USD Million)
11.3.3 Germany
11.3.3.1 Germany clinical trial imaging market, 2016 – 2028 (USD Million)
11.3.4 France
11.3.4.1 France clinical trial imaging market, 2016 – 2028 (USD Million)
11.3.5 Italy
11.3.5.1 Italy clinical trial imaging market, 2016 – 2028 (USD Million)
11.3.6 Spain
11.3.6.1 Spain clinical trial imaging market, 2016 – 2028 (USD Million)
11.4 Asia Pacific
11.4.1 Asia Pacific Clinical Trial Imaging Market, 2016 – 2028 (USD Million)
11.4.2 Japan
11.4.2.1 Japan clinical trial imaging market, 2016 – 2028 (USD Million)
11.4.3 China
11.4.3.1 China clinical trial imaging market, 2016 – 2028 (USD Million)
11.4.4 India
11.4.4.1 India clinical trial imaging market, 2016 – 2028 (USD Million)
11.4.5 Thailand
11.4.5.1 Thailand clinical trial imaging market, 2016 – 2028 (USD Million)
11.4.6 South Korea
11.4.6.1 South Korea clinical trial imaging market, 2016 – 2028 (USD Million)
11.5 Latin America
11.5.1 Latin America Clinical Trial Imaging Market, 2016 – 2028 (USD Million)
11.5.2 Brazil
11.5.2.1 Brazil clinical trial imaging market, 2016 – 2028 (USD Million)
11.5.3 Mexico
11.5.3.1 Mexico clinical trial imaging market, 2016 – 2028 (USD Million)
11.5.4 Argentina
11.5.4.1 Argentina clinical trial imaging market, 2016 – 2028 (USD Million)
11.5.5 Colombia
11.5.5.1 Colombia clinical trial imaging market, 2016 – 2028 (USD Million)
11.6 MEA
11.6.1 MEA Clinical Trial Imaging Market, 2016 – 2028 (USD Million)
11.6.2 South Africa
11.6.2.1 South Africa clinical trial imaging market, 2016 – 2028 (USD Million)
11.6.3 Saudi Arabia
11.6.3.1 Saudi Arabia clinical trial imaging market, 2016 – 2028 (USD Million)
11.6.4 UAE
11.6.4.1 UAE clinical trial imaging market, 2016 – 2028 (USD Million)
Chapter 12 Company Profiles
12.1 Strategic Framework
12.2 Company Profiles
12.2.1 Bioclinica
12.2.1.1 Company overview
12.2.1.2 Financial performance
12.2.1.3 Product benchmarking
12.2.1.4 Strategic initiatives
12.2.2 Icon
12.2.2.1 Company overview
12.2.2.2 Financial performance
12.2.2.3 Product benchmarking
12.2.2.4 Strategic initiatives
12.2.3 IXICO PLC
12.2.3.1 Company overview
12.2.3.2 Financial performance
12.2.3.3 Product benchmarking
12.2.3.4 Strategic initiatives
12.2.4 Navitas Life Sciences
12.2.4.1 Company overview
12.2.4.2 Financial performance
12.2.4.3 Product benchmarking
12.2.4.4 Strategic initiatives
12.2.5 Resonance Health
12.2.5.1 Company overview
12.2.5.2 Financial performance
12.2.5.3 Product benchmarking
12.2.5.4 Strategic initiatives
12.2.6 Proscan Imaging
12.2.6.1 Company overview
12.2.6.2 Financial performance
12.2.6.3 Product benchmarking
12.2.6.4 Strategic initiatives
12.2.7 Intrinsic Imaging
12.2.7.1 Company overview
12.2.7.2 Financial performance
12.2.7.3 Product benchmarking
12.2.7.4 Strategic initiatives
12.2.8 Radiant Sage LLC
12.2.8.1 Company overview
12.2.8.2 Financial performance
12.2.8.3 Product benchmarking
12.2.8.4 Strategic initiatives
12.2.9 Paraxel International Corporation
12.2.9.1 Company overview
12.2.9.2 Financial performance
12.2.9.3 Product benchmarking
12.2.9.4 Strategic initiatives
12.2.10 Medpace
12.2.10.1 Company overview
12.2.10.2 Financial performance
12.2.10.3 Product benchmarking
12.2.10.4 Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America clinical trial imaging devices market, by region, 2016 - 2028 (USD Million)
Table 3 North America clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 4 North America clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 5 North America clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 6 U.S. clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 7 U.S. clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 8 U.S. clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 9 Canada clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 10 Canada clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 11 Canada clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 12 Europe clinical trial imaging devices market, by region, 2016 - 2028 (USD Million)
Table 13 Europe clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 14 Europe clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 15 Europe clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 16 Germany clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 17 Germany clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 18 Germany clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 19 U.K. clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 20 U.K. clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 21 U.K. clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 22 France clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 23 France clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 24 France clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 25 Italy clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 26 Italy clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 27 Italy clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 28 Spain clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 29 Spain clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 30 Spain clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 31 APAC clinical trial imaging devices market, by region, 2016 - 2028 (USD Million)
Table 32 APAC clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 33 APAC clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 34 APAC clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 35 China clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 36 China clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 37 China clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 38 Japan clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 39 Japan clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 40 Japan clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 41 India clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 42 India clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 43 India clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 44 Thailand clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 45 Thailand clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 46 Thailand clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 47 South Korea clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 48 South Korea clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 49 South Korea clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 50 Latin America clinical trial imaging devices market, by region, 2016 - 2028 (USD Million)
Table 51 Latin America clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 52 Latin America clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 53 Latin America clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 54 Brazil clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 55 Brazil clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 56 Brazil clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 57 Mexico clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 58 Mexico clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 59 Mexico clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 60 Argentina clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 61 Argentina clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 62 Argentina clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 63 Colombia clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 64 Colombia clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 65 Colombia clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 66 Middle East and Africa clinical trial imaging devices market, by region, 2016 - 2028 (USD Million)
Table 67 Middle East and Africa clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 68 Middle East and Africa clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 69 Middle East and Africa clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 70 South Africa clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 71 South Africa clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 72 South Africa clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 73 Saudi Arabia clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 74 Saudi Arabia clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 75 Saudi Arabia clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)
Table 76 UAE clinical trial imaging devices market, by service, 2016 - 2028 (USD Million)
Table 77 UAE clinical trial imaging devices market, by application, 2016 - 2028 (USD Million)
Table 78 UAE clinical trial imaging devices market, by end use, 2016 - 2028 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Clinical trial imaging: market outlook
Fig. 14 Clinical trial imaging market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Clinical trial imaging market driver impact
Fig. 20 Clinical trial imaging market restraint impact
Fig. 21 Clinical trial imaging market strategic initiatives analysis
Fig. 22 Clinical trial imaging market: service movement analysis
Fig. 23 Clinical trial imaging market: service outlook and key takeaways
Fig. 24 Clinical trial design and consultation services market estimates and forecast, 2016 - 2028
Fig. 25 Reading and analytical services market estimates and forecast, 2016 - 2028
Fig. 26 Operational Imaging services market estimates and forecast, 2016 - 2028
Fig. 27 Computed Tomography (CT) Scan market estimates and forecast, 2016 - 2028
Fig. 28 MRI ( Magnetic Resonance Imaging) market estimates and forecast, 2016 - 2028
Fig. 29 X-ray market estimates and forecast, 2016 - 2028
Fig. 30 Ultrasound market estimates and forecast, 2016 - 2028
Fig. 31 Optical Coherence Tomography (OCT) market estimates and forecast, 2016 - 2028
Fig. 32 Others market estimates and forecast, 2016 - 2028
Fig. 33 System and technology support services market estimates and forecast, 2016 - 2028
Fig. 34 Project and data management market estimates and forecast, 2016 - 2028
Fig. 35 Clinical trial imaging market: application movement analysis
Fig. 36 Clinical trial imaging market: application outlook and key takeaways
Fig. 37 NASH market estimates and forecast, 2016 - 2028
Fig. 38 CKD estimates and forecast, 2016 - 2028
Fig. 39 Diabetes estimates and forecast, 2016 - 2028
Fig. 40 Cardiovascular diseases estimates and forecast, 2016 - 2028
Fig. 41 Others estimates and forecast, 2016 - 2028
Fig. 42 Clinical trial imaging market: end-use movement analysis
Fig. 43 Clinical trial imaging market: end-use outlook and key takeaways
Fig. 44 Biotechnology and pharmaceutical companies estimates and forecast, 2016 - 2028
Fig. 45 Medical devices manufacturers estimates and forecast, 2016 - 2028
Fig. 46 Academic and government research institutes estimates and forecast, 2016 - 2028
Fig. 47 Contract Research Organization (CROs) estimates and forecast, 2016 - 2028
Fig. 48 Others estimates and forecast, 2016 - 2028
Fig. 49 Global clinical trial imaging market: regional movement analysis
Fig. 50 Global clinical trial imaging market: regional outlook and key takeaways
Fig. 51 Global market share and leading players
Fig. 52 North America market share and leading players
Fig. 53 Europe market share and leading players
Fig. 54 Asia Pacific market share and leading players
Fig. 55 Latin America market share and leading players
Fig. 56 Middle East & Africa market share and leading players
Fig. 57 North America: SWOT
Fig. 58 Europe SWOT
Fig. 59 Asia Pacific SWOT
Fig. 60 Latin America SWOT
Fig. 61 MEA SWOT
Fig. 62 North America, by country
Fig. 63 North America
Fig. 64 North America market estimates and forecast, 2016 - 2028
Fig. 65 U.S.
Fig. 66 U.S. market estimates and forecast, 2016 - 2028
Fig. 67 Canada
Fig. 68 Canada market estimates and forecast, 2016 - 2028
Fig. 69 Europe
Fig. 70 Europe. market estimates and forecast, 2016 - 2028
Fig. 71 U.K.
Fig. 72 U.K. market estimates and forecast, 2016 - 2028
Fig. 73 Germany
Fig. 74 Germany market estimates and forecast, 2016 - 2028
Fig. 75 France
Fig. 76 France market estimates and forecast, 2016 - 2028
Fig. 77 Italy
Fig. 78 Italy market estimates and forecast, 2016 - 2028
Fig. 79 Spain
Fig. 80 Spain market estimates and forecast, 2016 - 2028
Fig. 81 Asia Pacific
Fig. 82 Asia Pacific market estimates and forecast, 2016 - 2028
Fig. 83 China
Fig. 84 China market estimates and forecast, 2016 - 2028
Fig. 85 Japan
Fig. 86 Japan market estimates and forecast, 2016 - 2028
Fig. 87 India
Fig. 88 India market estimates and forecast, 2016 - 2028
Fig. 89 Thailand
Fig. 90 Thailand market estimates and forecast, 2016 - 2028
Fig. 91 South Korea
Fig. 92 South Korea market estimates and forecast, 2016 - 2028
Fig. 93 Latin America
Fig. 94 Latin America market estimates and forecast, 2016 - 2028
Fig. 95 Brazil
Fig. 96 Brazil market estimates and forecast, 2016 - 2028
Fig. 97 Mexico
Fig. 98 Mexico market estimates and forecast, 2016 - 2028
Fig. 99 Argentina
Fig. 100 Argentina market estimates and forecast, 2016 - 2028
Fig. 101 Colombia
Fig. 102 Colombia market estimates and forecast, 2016 - 2028
Fig. 103 Middle East and Africa
Fig. 104 Middle East and Africa. market estimates and forecast, 2016 - 2028
Fig. 105 South Africa
Fig. 106 South Africa market estimates and forecast, 2016 - 2028
Fig. 107 Saudi Arabia
Fig. 108 Saudi Arabia market estimates and forecast, 2016 - 2028
Fig. 109 UAE
Fig. 110 UAE market estimates and forecast, 2016 - 2028
Fig. 111 Participant categorization- clinical trial imaging market
Fig. 112 Market share of key market players- clinical trial imaging market

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の臨床試験イメージング市場2021-2028:サービス別(プロジェクト・データ管理、システム・技術サポートサービス)、用途別、最終用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆